Cloudpharm is a bio-pharmaceutical R&D Company founded in Athens, Greece in 2016. They create cutting-edge machine learning and artificial intelligence algorithms towards drug repurposing and offer tailor-made computational services for drug discovery and development. They have developed Cloudscreen®, an AI powered Drug Repurposing platform to provide high quality data for the identification of new indications for existing approved or under investigation drugs.
Their “one-stop-shop” next generation platform combines textual and structural information for predicting and evaluating the efficacy and toxicity of repurposed biomolecules in new indications. Cloudpharm is seeking to build strategic partnerships with pharma companies for drug repurposing projects.